Observation on the Curative Effect of Assisted Reproduction by TCM Multi-channel Interventional Therapy
TCM Multi-channel Interventional Therapy for Assisting Reproduction
1 other identifier
interventional
100
1 country
1
Brief Summary
Objective: To evaluate the curative effect of TCM multi-channel interventional therapy on women with ART Failure; to compare the curative effect of the dual therapy and triple therapy on women with ART Failure; to choose the best TCM interventional therapeutic plan. Methods: The cases with ART Failure from West China second University Hospital of Sichuan University (West China Women's and Children's Hospital of Sichuan University) meeting the inclusion criteria were randomly divided into three groups: the dual therapy group, the triple therapy group and the control group, compare the natural pregnancy number, the condition during the period of secondary IVF-ET and the improvement of the kidney deficiency, liver depression and blood stasis syndrome among those three groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2016
CompletedFirst Submitted
Initial submission to the registry
March 8, 2017
CompletedFirst Posted
Study publicly available on registry
March 13, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2018
CompletedFebruary 17, 2020
February 1, 2020
1.7 years
March 8, 2017
February 13, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of patients with successful conception
10 weeks after embryo transplantation
Secondary Outcomes (2)
Time to have successful conception
up to 26 weeks
Adverse events
0, 10, 26 weeks after randomization
Study Arms (3)
The control group
NO INTERVENTIONNo Intervention
The dual therapy group
EXPERIMENTALTCM prescriptionⅡof cultivated emotion and assisted reproduction +auricular acupoint therapy.
The triple therapy group
EXPERIMENTALTCM prescriptionⅡof cultivated emotion and assisted reproduction + auricular acupoint therapy+ retention enema of TCM.
Interventions
TCM prescriptionⅡof cultivated emotion and assisted reproduction +auricular acupoint therapy
TCM prescriptionⅡof cultivated emotion and assisted reproduction + auricular acupoint therapy+ retention enema of TCM
Eligibility Criteria
You may qualify if:
- People aged 20 to 42
- People with IVF - ET indications
- People from Reproductive Center of West China second University Hospital of Sichuan University (West China Women's and Children's Hospital of Sichuan University) with long plan for IVE - ET Failure and then accept the secondary IVF-ET
- People who conform to the standard of syndrome differentiation in TCM: kidney deficiency and liver depression and blood stasis
- People with normal basic sex hormone levels
- People who have recognized and voluntarily signed the informed consent. NOTICE: People who conform to the above 6 items can be included.
You may not qualify if:
- The husband with less sperm and weak sperm seriously
- People who have drug allergy or allergic constitution
- People with serious primary diseases such as cardiovascular, liver, kidney and hematopoietic system, etc. And mentally disordered patients
- People who are complicated by acute infectious diseases and organic diseases
- People have confirmed diagnosis malformed reproductive organs, reproductive system inflammation and tumors upon examination
- People suffer from hereditary disease which is not suitable for fertility regulated in "maternal and infant health care law"
- People who have the serious bad habits such as drug use
- People who have contacted with birth defects rays, poison, drugs to a certain number and being in effect; NOTICE: People who conform to any of the terms above 9 will be ruled out.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
West China second University Hospital of Sichuan University
Chengdu, Sichuan, 610041, China
Related Publications (1)
Zhou H, Zheng X, Xia W, Ma Q, Li J, Zeng Q, Huang J. The Efficacy and Safety of the Zhuyun Formula and Auricular Acupressure for the Infertile Women with Recurrent Implantation Failure: A Randomized Controlled Trial. Evid Based Complement Alternat Med. 2022 Oct 11;2022:5274638. doi: 10.1155/2022/5274638. eCollection 2022.
PMID: 36267092DERIVED
Study Officials
- STUDY DIRECTOR
Qian Zeng
Chengdu University of Traditional Chinese Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
March 8, 2017
First Posted
March 13, 2017
Study Start
May 1, 2016
Primary Completion
January 1, 2018
Study Completion
April 1, 2018
Last Updated
February 17, 2020
Record last verified: 2020-02